Trop-2 Expression as a Biomarker of Response to Sacituzumab Govitecan in Patients with Metastatic Breast Cancer: A Pilot Study
Year: 2024
Type: preprint
Source: SSRN Electronic Journal
DOI: 10.2139/ssrn.4924756
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: green
OpenAlex ID: W4401855768
